Tumor Markers: Strategic Assessments of Current and Emerging Competitors

Name: Tumor Markers: Strategic Assessments of Current and Emerging Competitors
Brand: Venture Planning Group
SKU: T8E5D887E37EN
Price: 2000.00 USD
Availability: InStock

July 2016 | 80 pages | ID: T8E5D887E37EN
Venture Planning Group

US$ 2,000.00 ~~US$ 2,500.00~~ -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

Abstracts
Contents

This new 80-page report from VPGMarketResearch.com provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include: Sales Product portfolios Distribution tactics Technological know-how New products in R&D Collaborative arrangements Business strategies.

Abbott
AdnaGen/Alere
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
BioRad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Epigenomics
Enterix
Enzo Biochem
Exact Sciences
Fujirebio
Guided Therapeutics
Hologic/GenProbe
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
OrthoClinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Thermo Fisher
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila

More Publications

CompetitiveWatch Tumor Markers: Strategic Assessments of Major Suppliers US$ 2,000.00 May 2013 80 pages

Blood Typing, Grouping and Infectious Disease NAT Screening: Strategic Assessments of Current and Emerging Competitors US$ 2,800.00 July 2016 225 pages

2015-2019 France Hospital Tumor Marker Testing Market Forecasts and Emerging Opportunities for Suppliers - Competitive Landscape, Supplier Shares by Test, Innovative Technologies, Instrumentation Review US$ 3,080.00 July 2015 533 pages

2015-2019 Germany Hospital Tumor Marker Testing Market Forecasts and Emerging Opportunities for Suppliers - Competitive Landscape, Supplier Shares by Test, Innovative Technologies, Instrumentation Review US$ 3,080.00 July 2015 530 pages

2015-2019 Italy Hospital Tumor Marker Testing Market Forecasts and Emerging Opportunities for Suppliers - Competitive Landscape, Supplier Shares by Test, Innovative Technologies, Instrumentation Review US$ 3,080.00 July 2015 525 pages

Tumor Markers: Strategic Assessments of Current and Emerging Competitors

More Publications

Need Help?

Ask a Question

Market Reports